Lumida
/FIGS
⌘K
Figs Inc

Figs Inc

FIGS
$10.31USD-0.10%-0.01 today

MARKET CAP

1.7B

P/E (TTM)

46.9x

FWD P/E

34.3x

DAY RANGE

$10 – $11

52W RANGE

$6
$17

AI Summary

Stalk
TrimMedium

FIGS remains in a Stage 4 decline with bearish medium-term bias. Price is extreme oversold and extended below the 9 EMA, 21 EMA, 50 DMA, and 200 DMA, making immediate selling unfavorable. Better execution involves trimming into relief rallies near declining EMAs acting as dynamic resistance. Primary risks include shallow relief bounces trapping sellers and the potential for deeper breakdown before a rebound.

  • Q1 net revenue rose 28% YoY to $159.9M, broad-based strength.
  • Active customers surpassed 3.0M, a 12% YoY increase.
  • Negative earnings yield and weak profitability factors signal returns risk.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

FIGS, Inc. (NYSE: FIGS) is a leading player in the healthcare apparel industry, specializing in premium medical scrubs and related accessories. The company operates with a direct-to-consumer model focused on providing high-quality products tailored to healthcare professionals. As a market leader, FIGS is well-positioned to capitalize on the growing demand for healthcare services, driven by a stable workforce expansion in the healthcare sector.

Bull says

  • Q1 net revenue rose 28% YoY to $159.9M, broad-based strength.
  • Active customers surpassed 3.0M, a 12% YoY increase.
  • Adjusted EBITDA margin expanded to 8.7% from 7.3% YoY.
  • International revenue climbed 50% YoY to $28.3M.
  • New FiberX fabric and community hubs boosted customer acquisition.
  • Strong momentum and growing healthcare demand support growth.

Bear says

  • Negative earnings yield and weak profitability factors signal returns risk.
  • Tariff headwinds press gross margin, risking future margin compression.
  • High short interest reflects market doubt on near-term outlook.
  • Elevated leverage risk raises questions about financial stability.
  • Replenishment model vulnerable to healthcare employment downturns.
  • Market saturation and price sensitivity could curb growth momentum.

Investment themes with FIGS

eTailing +0.56%

Online retail and e-commerce platforms

FIGS · LQDT · CVNA

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 05-28-2026neutral

Transcript signals

Bull points

  • Q1 revenues up 5% year-over-year and outperforming our expectations.
  • Bottom line performance also exceeded expectations, driven in large part by our top line improvements, adjusted EBITDA margin of 7.2%, came in above our 5.5% to 6% target,
  • we are excited to now make this program permanent. We think this is another powerful differentiator for our brand, and we're encouraged with our recent activation in Houston, which tripled the volume of donations seen at last year's corresponding event in Philly.

Bear points

  • the speed at which global trade policy is evolving, it's important to pinpoint where they will ultimately land and how much they will increase our cost over time.
  • we believe we're uniquely positioned with suppliers for three reasons. First, the majority of our assortment is non-seasonal. Second, our products are replenishment-driven. And third, our mix is centered around high volume, low skew count core scrubware.
  • We continue to see the impact of higher cost structure of our new fulfillment center, which we are actively optimizing and scaling.
Read full transcript analysis ›